# Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use, Division 3.3.2.5: Developmental studies

Extent: E+W+S+N.I.

The description of the development program shall address the choice of materials and processes. In particular, the integrity of the cell population as in the final formulation shall be discussed.

---
Source: https://www.legislation.gov.uk/eudr/2001/83/annex/I/part/IV/division/3/division/3.3/division/3.3.2/division/3.3.2.5 (the official version)
Page: https://openlegislation.uk/eu-directive-2001-83/annex-I/part-IV/division-3/division-3.3/division-3.3.2/division-3.3.2.5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.